I H M Borel Rinkes
Overview
Explore the profile of I H M Borel Rinkes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andel D, Ramdhani K, Braat A, Bruijnen R, Bol G, Keane G, et al.
Cardiovasc Intervent Radiol
. 2024 Nov;
48(3):379-385.
PMID: 39604694
Purpose: To describe the outcome of radiation lobectomy (RL) after double vein embolization (portal vein embolization + hepatic vein embolization) for patients with insufficient future liver remnant growth. Materials And...
2.
Korenblik R, Olij B, Aldrighetti L, Abu Hilal M, Ahle M, Arslan B, et al.
Cardiovasc Intervent Radiol
. 2022 Jul;
45(9):1391-1398.
PMID: 35790566
Study Purpose: The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients...
3.
Andel D, Dassen M, Reinders-Hut M, Peters N, Kranenburg O, Lam M, et al.
Br J Surg
. 2020 Sep;
107(12):e609-e610.
PMID: 32936446
No abstract available.
4.
Pasternak J, Imisairi A, Rinkes I, Kruijff S
World J Surg
. 2020 May;
44(8):2667-2668.
PMID: 32424458
No abstract available.
5.
van Beek D, Nell S, Verkooijen H, Rinkes I, Valk G, Vriens M
Br J Surg
. 2020 May;
107(11):1489-1499.
PMID: 32352164
Background: Insulinomas are found in 10-15 per cent of patients with multiple endocrine neoplasia type 1 (MEN1) and lead to life-threatening hypoglycaemia. Surgical outcome and the optimal surgical strategy for...
6.
Ubink I, Bolhaqueiro A, Elias S, Raats D, Constantinides A, Peters N, et al.
Br J Surg
. 2019 Jun;
106(10):1404-1414.
PMID: 31197820
Background: Patients with peritoneal metastases from colorectal cancer have a poor prognosis. If the intraperitoneal tumour load is limited, patients may be eligible for cytoreductive surgery followed by hyperthermic intraperitoneal...
7.
Buisman F, Homs M, Grunhagen D, Filipe W, Bennink R, Besselink M, et al.
BMC Cancer
. 2019 Apr;
19(1):327.
PMID: 30953467
Background: Recurrences are reported in 70% of all patients after resection of colorectal liver metastases (CRLM), in which half are confined to the liver. Adjuvant hepatic arterial infusion pump (HAIP)...
8.
Conemans E, Lodewijk L, Moelans C, Offerhaus G, Pieterman C, Morsink F, et al.
Eur J Endocrinol
. 2018 Jun;
179(3):153-160.
PMID: 29903750
Objective: Epigenetic changes contribute to pancreatic neuroendocrine tumor (PanNET) development. Hypermethylation of promoter DNA as a cause of tumor suppressor gene silencing is a well-established oncogenic mechanism that is potentially...
9.
Ubink I, van Eden W, Snaebjornsson P, Kok N, van Kuik J, van Grevenstein W, et al.
Br J Surg
. 2018 Jan;
105(2):e204-e211.
PMID: 29341165
Background: Patients with colorectal peritoneal carcinomatosis have a very poor prognosis. The recently developed consensus molecular subtype (CMS) classification of primary colorectal cancer categorizes tumours into four robust subtypes, which...
10.
Conemans E, Raicu-Ionita G, Pieterman C, Dreijerink K, Dekkers O, Hermus A, et al.
J Endocrinol Invest
. 2017 Nov;
41(6):655-661.
PMID: 29134609
Purpose: Pancreatic neuroendocrine tumors are a major manifestation of multiple endocrine neoplasia type 1 (MEN1). This tumor syndrome is caused by germline mutations in MEN1, encoding menin. Insight into pathogenesis...